Literature DB >> 16810246

Potential of stem-cell-based therapies for heart disease.

Deepak Srivastava1, Kathryn N Ivey.   

Abstract

The use of stem cells to generate replacement cells for damaged heart muscle, valves, vessels and conduction cells holds great potential. Recent identification of multipotent progenitor cells in the heart and improved understanding of developmental processes relevant to pluripotent embryonic stem cells may facilitate the generation of specific types of cell that can be used to treat human heart disease. Secreted factors from circulating progenitor cells that localize to sites of damage may also be useful for tissue protection or neovascularization. The exciting discoveries in basic science will require rigorous testing in animal models to determine those most worthy of future clinical trials.

Entities:  

Mesh:

Year:  2006        PMID: 16810246     DOI: 10.1038/nature04961

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

1.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 2.  Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment.

Authors:  Georgina M Ellison; Bernardo Nadal-Ginard; Daniele Torella
Journal:  J Cardiovasc Transl Res       Date:  2012-06-12       Impact factor: 4.132

3.  Monkeying around with cardiac progenitors: hope for the future.

Authors:  Li Qian; Deepak Srivastava
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

4.  Heart of newt: a recipe for regeneration.

Authors:  Bhairab N Singh; Naoko Koyano-Nakagawa; John P Garry; Cyprian V Weaver
Journal:  J Cardiovasc Transl Res       Date:  2010-06-16       Impact factor: 4.132

Review 5.  Interactome of a cardiopoietic precursor.

Authors:  Randolph S Faustino; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2008-06-03       Impact factor: 4.132

6.  A whole-mechanical method to establish human embryonic stem cell line HN4 from discarded embryos.

Authors:  Bin Li; Lan Xu; Wei-Ying Lu; Wen Xu; Mei-Hong Wang; Ke Yang; Juan Dong; Xiao-Yan Ding; Yuan-Hua Huang
Journal:  Cytotechnology       Date:  2010-10-26       Impact factor: 2.058

7.  Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.

Authors:  Atta Behfar; Satsuki Yamada; Ruben Crespo-Diaz; Jonathan J Nesbitt; Lois A Rowe; Carmen Perez-Terzic; Vinciane Gaussin; Christian Homsy; Jozef Bartunek; Andre Terzic
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

Review 8.  Gene therapy to create biological pacemakers.

Authors:  Gerard J J Boink; Jurgen Seppen; Jacques M T de Bakker; Hanno L Tan
Journal:  Med Biol Eng Comput       Date:  2006-10-18       Impact factor: 2.602

9.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

10.  Conditioned medium enhances the fusion capability of rat bone marrow mesenchymal stem cells and cardiomyocytes.

Authors:  Kanwal Haneef; Nadia Naeem; Irfan Khan; Hana'a Iqbal; Nurul Kabir; Siddiqua Jamall; Muniza Zahid; Asmat Salim
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.